Demographic and clinical characteristics
| Study Group | Control Group | P Value | |
|---|---|---|---|
| No. | 29 | 15 | |
| Sex, M/F | 10/19 | 11/4 | .03 |
| Age, y | 46.4 ± 9.5 | 42.6 ± 7.1 | .18 |
| Disease duration, y | 12.6 ± 6.7 | NA | |
| Disease course (RR/SP/PP) | 17/8/4 | NA | |
| EDSS | 3.6 ± 2.1 (1.0–7.0) | NA |
Note:—NA indicates not applicable; RR, relapsing-remitting; SP, secondary-progressive; PP, primary-progressive.